Rhumbline Advisers »

Dechra Pharmaceuticals - shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Dechra Pharmaceuticals - shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Dechra Pharmaceuticals -

Tip: Access up to 7 years of quarterly data

All positions including Dechra Pharmaceuticals - held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dechra Pharmaceuticals - by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.3k 34 98.00
2023-12-31 $3.3k 34 98.35
2023-09-30 $3.1k 34 92.44
2023-06-30 $3.2k 34 93.71

More positions owned by Rhumbline Advisers

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Facebook Inc cl a (META)
Alphabet Inc Class A cs (GOOGL)
Alphabet Inc Class C cs (GOOG)
Berkshire Hathaway (BRK.B)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Visa (V)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)

View all positions for Rhumbline Advisers

Top funds holding Dechra Pharmaceuticals -

Rhumbline Advisers

View all funds holding Dechra Pharmaceuticals -